共 43 条
- [21] Wassel M.M., Ammar Y.A., Ali G.A.E., Belal A., Mehany A.B., Ragab A: development of adamantane scaffold containing 1, 3, 4-thiadiazole derivatives: design, synthesis, anti-proliferative activity and molecular docking study targeting EGFR, Bioorg. Chem., 110, (2021)
- [22] George R.F., Kandeel M., El-Ansary D.Y., El Kerdawy A.M., Some 1, 3, 5-trisubstituted pyrazoline derivatives targeting breast cancer: design, synthesis, cytotoxic activity, EGFR inhibition and molecular docking, Bioorg. Chem., 99, (2020)
- [23] Al-Anazi M., Khairuddean M., Al-Najjar B.O., Alidmat M.M., Kamal N.N.S.N.M., Muhamad M: synthesis, anticancer activity and docking studies of pyrazoline and pyrimidine derivatives as potential epidermal growth factor receptor (EGFR) inhibitors, Arab. J. Chem., 15, 7, (2022)
- [24] Nawaz F., Alam O., Perwez A., Rizvi M.A., Naim M.J., Siddiqui N., Pottoo F.H., Jha M., 3′-(4-(Benzyloxy) phenyl)-1′-phenyl-5-(heteroaryl/aryl)-3, 4-dihydro-1′ H, 2H-[3, 4′-bipyrazole]-2-carboxamides as EGFR kinase inhibitors: synthesis, anticancer evaluation, and molecular docking studies, Arch. Pharm. (Weinheim), 353, 4, (2020)
- [25] Serag M.I., Tawfik S.S., Badr S.M., Eisa H.M., New oxadiazole and pyrazoline derivatives as anti-proliferative agents targeting EGFR-TK: design, synthesis, biological evaluation and molecular docking study, Sci. Rep., 14, 1, (2024)
- [26] Gangadhar K.H., Benarjee V., Ratnamala A., Coumarin-Piperazine tethered 1, 2, 3-triazoles: EGFR targeting anti-breast cancer evaluation and molecular docking studies, Polycycl. Aromat. Compd., pp. 1-17, (2023)
- [27] Basappa B., Chumadathil Pookunoth B., Shinduvalli Kempasiddegowda M., Knchugarakoppal Subbegowda R., Lobie P.E., Pandey V., Novel biphenyl amines inhibit oestrogen receptor (ER)-α in ER-positive mammary carcinoma cells, Molecules, 26, 4, (2021)
- [28] Anusha S., Mohan C.D., Ananda H., Baburajeev C., Rangappa S., Mathai J., Fuchs J.E., Li F., Shanmugam M.K., Bender A., Adamantyl-tethered-biphenylic compounds induce apoptosis in cancer cells by targeting Bcl homologs, Bioorg. Med. Chem. Lett., 26, 3, pp. 1056-1060, (2016)
- [29] Anusha S., Cp B., Mohan C.D., Mathai J., Rangappa S., Mohan S., Chandra P.S., Mervin L., Fuchs J.E., A nano-MgO and ionic liquid-catalyzed ‘green'synthesis protocol for the development of adamantyl-imidazolo-thiadiazoles as anti-tuberculosis agents targeting sterol 14α-demethylase (CYP51), PLoS. One, 10, 10, (2015)
- [30] Yang M.H., Sethi G., Ravish A., Mohan A.K., Pandey V., Lobie P.E., Basappa S., Basappa B., Ahn K.S., Discovery of imidazopyridine-pyrazoline-hybrid structure as SHP-1 agonist that suppresses phospho-STAT3 signaling in human breast cancer cells, Chem. Biol. Interact., 386, (2023)